- /
- Supported exchanges
- / US
- / NPRRF.PINK
Nipro Corp (NPRRF PINK) stock market data APIs
Nipro Corp Financial Data Overview
Nipro Corporation, together with its subsidiaries, engages in the medical devices, pharmaceuticals, and pharma packaging businesses. Its Medical Device business develops, manufactures, and sells medical equipment for injection-infusion and dialysis treatment, and products related to diabetes and cell cultures, as well as the sale of artificial organ-related products. The company's Pharmaceutical business provides pharmaceutical combination products, including dual chamber bags, pre-filled syringes, and half-type kits; and contract manufacturing services for orally administered drugs, injectables, and external preparations, as well as logistic and distribution services. Its Pharma Packaging business offers glass products and other comprehensive pharmaceutical packaging, such as glass vials, ampoules, and syringes; tube glass; and other parts of pharmaceutical packaging, such as rubber plugs, as well as provides glass for thermos bottles, and lighting and containers. The company also offers business management services. It serves customers in Japan, the Americas, Europe, and rest of Asia. The company was founded in 1947 and is headquartered in Osaka, Japan.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Nipro Corp data using free add-ons & libraries
Get Nipro Corp Fundamental Data
Nipro Corp Fundamental data includes:
- Net Revenue: 483 831 M
- EBITDA: 67 481 M
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-08-10
- EPS/Forecast: 13.55
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Nipro Corp News
New
STEMIRAC Clinical, Regulatory and Commercial Intelligence Report 2026: Highlights Growth Opportunities in Spinal Cord Injury Treatment
Company Logo Examines STEMIRAC market potential, clinical development, regulatory milestones, competitive positioning, pricing, reimbursement and sales forecasts across seven major pharmaceutical mar...
Drug Reconstitution Systems Market Trends, Shares and Growth Opportunities Worldwide 2026-2035 Featuring Profiles of Baxter, ICU Medical, B. Braun, Vetter Pharma, Nipro, SCHOTT-KAISHA
Company Logo Dublin, Sept. 07, 2026 (GLOBE NEWSWIRE) -- The "Drug Reconstitution Systems Market - Trends and Forecast Till 2035" has been added to ResearchAndMarkets.com's offering. The global drug ...
Linear Health Sciences Expands Global Reach with NIPRO CORPORATION Partnership
Japanese Market Entry Signals Global Expansion for IV Safety Innovation OKLAHOMA CITY, July 13, 2026 /PRNewswire/ -- Linear Health Sciences announced that leading Japanese medical device manufacturer...
Samsung Bioepis Launches Ustekinumab Biosimilar, Marking Its First Product Launch in Japan
Ustekinumab BS 45 mg Syringe for S.C. Injection「NIPRO」 is now available in Japan, after its listing under the National Health Insurance (NHI) Drug Price Standard Marks first launch in Japan throug...
Corporate Events Calendar & News package for
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.